Risk for Death From Cardiovascular Disease in Women With Obstructive Sleep Apnea. Ann Intern Med. 2012;156:I-38. doi: 10.7326/0003-4819-156-2-201201170-00002
Download citation file:
Published: Ann Intern Med. 2012;156(2):I-38.
Obstructive sleep apnea (OSA) is a common medical problem that involves temporary interruptions of airflow while sleeping. Typical symptoms of OSA include snoring; pauses in the patient's breathing while asleep, as witnessed by others; and excessive sleepiness during the daytime. It may be treated by wearing a mask that gently blows air into the nose or mouth to prevent the interruption of airflow while sleeping, a treatment called continuous positive airway pressure (CPAP). In addition to daytime fatigue and other health problems, OSA is known to increase the risk for death in men due to cardiovascular problems (such as heart attacks). Treatment with CPAP can reduce that risk. Much less is known about the risk of OSA to women.
To find out whether women with OSA are at an increased risk for death due to cardiovascular problems and whether CPAP therapy is associated with a decreased risk.
1116 women sent by their physicians to sleep medicine treatment clinics in Spain.
All the women underwent a study while they slept to determine whether they had OSA. If they did and the disease was severe or they had symptoms caused by OSA, they were prescribed CPAP therapy. The researchers evaluated a database in which information on these women had been collected between 1998 and 2007 to see whether the presence of OSA was associated with death due to a cardiovascular problem (such as stroke, heart attack, or heart failure) and whether the use of CPAP was associated with a diminished risk.
Deaths due to cardiovascular problems were more frequent in women who had OSA that was not treated with CPAP, particularly when the OSA was severe. The rate of deaths from cardiovascular problems in women with severe OSA who used CPAP therapy was not increased compared with women who had no OSA.
This was an observational study, not a clinical trial. The study cannot tell whether OSA caused the increased rates of death observed, or whether the risk was reduced by CPAP therapy rather than other factors that might be associated with OSA or use of CPAP.
The study supports the notion that OSA is a risk for death due to cardiovascular problems in women, as has been shown in men. More research and greater attention to OSA in women is warranted.
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Pulmonary/Critical Care, Sleep Disorders.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only